|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-11-6
|
|
pubmed:abstractText |
Precise evaluation of the haemocompatibility of prototype membranes, flow configurations and anticoagulant regimens is an essential step in the development of dialysis systems minimizing blood activation. An ex vivo model in humans currently employed in our laboratory has recently been adapted to allow the parallel evaluation of two minimodule dialysers with blood from a single donor, thus eliminating differences due to donor variability in the comparison of test and control dialysis modules.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants,
http://linkedlifedata.com/resource/pubmed/chemical/Antithrombin III,
http://linkedlifedata.com/resource/pubmed/chemical/Biocompatible Materials,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C3a,
http://linkedlifedata.com/resource/pubmed/chemical/Heparin,
http://linkedlifedata.com/resource/pubmed/chemical/Membranes, Artificial,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/antithrombin III-protease complex,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Thromboglobulin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1968-73
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9306352-Adolescent,
pubmed-meshheading:9306352-Adult,
pubmed-meshheading:9306352-Anticoagulants,
pubmed-meshheading:9306352-Antithrombin III,
pubmed-meshheading:9306352-Biocompatible Materials,
pubmed-meshheading:9306352-Blood Coagulation,
pubmed-meshheading:9306352-Complement Activation,
pubmed-meshheading:9306352-Complement C3a,
pubmed-meshheading:9306352-Evaluation Studies as Topic,
pubmed-meshheading:9306352-Heparin,
pubmed-meshheading:9306352-Humans,
pubmed-meshheading:9306352-Leukocyte Count,
pubmed-meshheading:9306352-Male,
pubmed-meshheading:9306352-Membranes, Artificial,
pubmed-meshheading:9306352-Peptide Fragments,
pubmed-meshheading:9306352-Peptide Hydrolases,
pubmed-meshheading:9306352-Platelet Activation,
pubmed-meshheading:9306352-Platelet Count,
pubmed-meshheading:9306352-Prothrombin,
pubmed-meshheading:9306352-Reference Values,
pubmed-meshheading:9306352-Renal Dialysis,
pubmed-meshheading:9306352-beta-Thromboglobulin
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Evaluation of haemodialysis membrane biocompatibility by parallel assessment in an ex vivo model in healthy volunteers.
|
|
pubmed:affiliation |
INSERM U.311, Laboratoire de Biologie et Pharmacologie des Interactions du Sang avec les Vaisseaux et les Biomatériaux, Etablissement de Transfusion Sanguine, Strasbourg, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
